Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Dermatologic 2Sarcoma 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 22Glioblastoma 15Gliosarcoma 13Prostatic Neoplasms 12Squamous Cell Carcinoma of Head and Neck 11Head and Neck Neoplasms 10Breast Neoplasms 10Pancreatic Neoplasms 9Lung Neoplasms 9Brain Neoplasms 7Adenocarcinoma of Lung 6Salivary Gland Neoplasms 5Astrocytoma 5Rectal Neoplasms 4Neoplasm Metastasis 4Glioma 4Central Nervous System Neoplasms 4Adenocarcinoma, Bronchiolo-Alveolar 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Stomach Neoplasms 3Sarcoma 3Ovarian Neoplasms 3Oligodendroglioma 3Liver Neoplasms 3Colorectal Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Carcinoma, Hepatocellular 3Carcinoma, Ductal, Breast 3Wilms Tumor 2

Interventions

pembrolizumab 287Nivolumab 258Ipilimumab 236Cyclophosphamide 135aldesleukin 134Interleukin-2 104Temozolomide 75Dacarbazine 74trametinib 70Vemurafenib 69fludarabine 68dabrafenib 65fludarabine phosphate 62sargramostim 44binimetinib 44Radiosurgery 44Biopsy 43Paclitaxel 42Bevacizumab 42incomplete Freund's adjuvant 39encorafenib 37Radiotherapy 36Cisplatin 36CTLA-4 Antigen 36atezolizumab 35Carboplatin 35Magnetic Resonance Spectroscopy 33cobimetinib 32Specimen Handling 31Introns 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Melanoma × Radiotherapy, Conformal × Clear all
NCT00550654 2017-01-13

Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
1 enrolled 7 charts
DermatologicGenitourinaryGynecologicSarcoma

Carcinoma, Renal Cell, Chondrosarcoma, Kidney Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Sarcoma, Osteosarcoma

NCT00553683 2014-01-14

Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer

Rutgers, The State University of New Jersey

Phase 1/2 Unknown
50 enrolled
BreastDermatologicGastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Colonic Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡